Comparative efficacy and safety of stimulant-type medications for depression: A systematic review and network meta-analysis
Author:
Publisher
Elsevier BV
Subject
Psychiatry and Mental health,Clinical Psychology
Reference60 articles.
1. Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials;Abbasowa;Nord. J. Psychiatry,2013
2. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression;Abolfazli;Depress. Anxiety,2011
3. Comparative efficacy and tolerability of adjunctive pharmacotherapies for acute bipolar depression: a systematic review and network meta-analysis;Bahji;Can. J. Psychiatry Rev. Can. Psychiatr.,2021
4. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis;Bahji;J. Affect. Disord.,2020
5. Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis;Bahji;J. Psychiatr. Res.,2020
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes;The Canadian Journal of Psychiatry;2024-05-06
2. Palliative and Supportive Medicine in Gastrointestinal Oncology;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23
3. Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021;Drug and Alcohol Dependence Reports;2023-06
4. Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases;Current Medicinal Chemistry;2023-06
5. Stimulants in Bipolar Depression: Risks and Benefits;Psychiatric Annals;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3